Literature DB >> 30916031

Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit.

M L'Heudé1, S Poignant2, D Elaroussi1, F Espitalier1, M Ferrandière1, M Laffon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30916031     DOI： 10.1016/j.bja.2019.02.009

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  6 in total

1.  Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?

Authors:  Jeremy R Beitler; Daniel Talmor
Journal:  Intensive Care Med       Date:  2022-09-03       Impact factor: 41.787

2.  Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?

Authors:  Patrick M Honore; David De Bels; Leonel Barreto Gutierrez; Sebastien Redant; Andrea Gallerani; Willem Boer
Journal:  Crit Care       Date:  2019-09-05       Impact factor: 9.097

3.  Use of volatile agents for sedation in the intensive care unit: A national survey in France.

Authors:  Raiko Blondonnet; Audrey Quinson; Céline Lambert; Jules Audard; Thomas Godet; Ruoyang Zhai; Bruno Pereira; Emmanuel Futier; Jean-Etienne Bazin; Jean-Michel Constantin; Matthieu Jabaudon
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

4.  Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial.

Authors:  Pierre Bailly; Pierre-Yves Egreteau; Stephan Ehrmann; Arnaud W Thille; Christophe Guitton; Guillaume Grillet; Florian Reizine; Olivier Huet; S Jaber; Emmanuel Nowak; Erwan L'her
Journal:  BMJ Open       Date:  2021-02-19       Impact factor: 2.692

5.  Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression.

Authors:  Camie Dupuis; Arnaud Robert; Ludovic Gerard; Johann Morelle; Pierre-François Laterre; Philippe Hantson
Journal:  Case Rep Anesthesiol       Date:  2022-03-11

6.  Sevoflurane, a sigh of relief in COVID-19?

Authors:  Gertrude J Nieuwenhuijs-Moeke; Jayant S Jainandunsing; Michel M R F Struys
Journal:  Br J Anaesth       Date:  2020-05-01       Impact factor: 9.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.